Pharmaceutical Preparations Industry - SEC Form 4 Insider Trading Screener

Manufacturing Sector - Chemicals - Pharmaceutical Preparations
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
 P - Purchase
 S - Sale
 A - Grant
 D - Sale to Iss
 G - Gift
 F - Tax
 M - Option Ex
 X - Option Ex
 C - Cnv Deriv
 W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title     Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10%own
  Other
Group by
Sort by
Max Results
Page
   clear
100 results. Finviz
TCcnt1d1w1m6m

X

Filing Date

Trade Date

Ticker

Company Name

Insider Name

Title

Trade Type  

Price

Qty

Owned

ΔOwn

Value

1d

1w

1m

6m

D
2025-07-16
AKROAkero Therapeutics, Inc.Yale CatrionaChief Development OfficerS - Sale+OE$52.95-10,00091,488-10%-$529,467
2025-07-17
IRONDisc Medicine, Inc.Franchi Jean M.CFOS - Sale$59.00-2,03163,499-3%-$119,829
2025-07-16
SNDXSyndax Pharmaceuticals IncGoldan Keith A.CFOS - Sale$9.29-1,29692,450-1%-$12,033
2025-07-16
SNDXSyndax Pharmaceuticals IncMetzger Michael ACEOS - Sale$9.29-7,534298,661-2%-$69,953
DM
2025-07-16
MDGLMadrigal Pharmaceuticals, Inc.Friedman Paul ADirS - Sale+OE$353.19-28,876842,704-3%-$10,198,844
2025-07-17
JNJJohnson & JohnsonReed John CEVP, Innovative Medicine, R, DS - Sale$163.55-19,13710,658-64%-$3,129,830
DM
2025-07-16
MDGLMadrigal Pharmaceuticals, Inc.Taub RebeccaDirS - Sale+OE$353.19-29,1011,116,584-3%-$10,278,098
2025-07-17
ESPREsperion Therapeutics, Inc.Looker BenjaminGCS - Sale$1.13-1,304399,9370%-$1,470
2025-07-17
ESPREsperion Therapeutics, Inc.Halladay BenjaminCFOS - Sale$1.12-11474,4620%-$12
D
2025-07-17
MRUSMerus N.V.Silverman Peter B.COO, GCS - Sale+OE$60.00-25,0000-100%-$1,500,000
2025-07-16
PHATPhathom Pharmaceuticals, Inc.Breedlove Robert CharlesPrincipal Accounting OfficerS - Sale$8.36-1,69253,500-3%-$14,152
D
2025-07-17
APLSApellis Pharmaceuticals, Inc.Francois CedricCEOS - Sale+OE$20.21-19,7251,871,027-1%-$398,735
2025-07-16
APLSApellis Pharmaceuticals, Inc.Watson David O.GCS - Sale$19.55-5,000208,866-2%-$97,750
2025-07-18
CALCCalcimedica, Inc.Wilson Robert NDirP - Purchase$2.87+4,500422,029+1%+$12,915
2025-07-18
CALCCalcimedica, Inc.Roberts Eric WCHIEF BUSINESS OFFICER, 10%P - Purchase$2.88+2,0001,010,9100%+$5,760
2025-07-17
GALTGalectin Therapeutics IncFreeman Kevin DDirP - Purchase$2.90+5,000147,832+4%+$14,495
2025-07-16
MNKDMannkind CorpBinder Steven B.DirS - Sale$3.94-75,367830,508-8%-$296,946
2025-07-16
MNKDMannkind CorpThomson DavidEVP Genl Counsel, SecretaryS - Sale$3.94-7,466841,719-1%-$29,416
2025-07-15
ETNB89Bio, Inc.Le-Nguyen QuocSee RemarksS - Sale$11.02-10,461323,580-3%-$115,280
2025-07-15
PTCTPtc Therapeutics, Inc.Gravier PierreCFOS - Sale$49.46-2,51671,920-3%-$124,441
DM
2025-07-15
NAMSNewamsterdam Pharma Co N.V.Kling Douglas FCOOS - Sale+OE$21.26-98,61244,000-69%-$2,096,655
DM
2025-07-15
NUVLNuvalent, Inc.Balcom AlexandraCFOS - Sale+OE$84.67-20,00061,734-24%-$1,693,496
D
2025-07-15
NUVLNuvalent, Inc.Porter James RichardPres, CEOS - Sale+OE$82.27-27,000249,062-10%-$2,221,419
D
2025-07-15
CNTACentessa Pharmaceuticals PlcHussain Iqbal JGCS - Sale+OE$14.93-6,000110,886-5%-$89,567
D
2025-07-14
SERSerina Therapeutics, Inc.Moreadith RandallChief Scientific OfficerS - Sale+OE$5.01-6,5000-100%-$32,565
D
2025-07-14
MNPRMonopar TherapeuticsTsuchimoto Kim RDirS - Sale+OE$40.00-8,90411,486-44%-$356,171
D
2025-07-14
MNPRMonopar TherapeuticsStarr Christopher MDirS - Sale+OE$40.00-16,80015,053-53%-$672,020
D
2025-07-14
MNPRMonopar TherapeuticsRobinson ChandlerCEOS - Sale+OE$40.00-16,800895,727-2%-$672,020
2025-07-14
TBPHTheravance Biopharma, Inc.Farnum RhondaSVP, COMM, MEDICAL AFFAIRSS - Sale$11.39-10,000326,918-3%-$113,870
D
2025-07-14
KNSAKiniksa Pharmaceuticals International, PlcTessari EbenCOOS - Sale+OE$28.72-18,90049,163-28%-$542,808
2025-07-14
ANNXAnnexon, Inc.Yednock TedEVP, CHIEF INNOVATION OFFICERS - Sale$2.58-1,116105,084-1%-$2,879
2025-07-14
ANNXAnnexon, Inc.Lew JenniferEVP, CFOS - Sale$2.58-1,117121,616-1%-$2,882
2025-07-14
ANNXAnnexon, Inc.Overdorf MichaelEVP, CHIEF BUSINESS OFFICERS - Sale$2.61-853130,689-1%-$2,226
2025-07-15
RAPPRapport Therapeutics, Inc.Bredt DavidChief Scientific OfficerS - Sale$14.00-8,500435,142-2%-$118,962
DM
2025-07-14
APLSApellis Pharmaceuticals, Inc.Francois CedricCEOS - Sale+OE$20.19-139,3651,881,755-7%-$2,813,091
2025-07-14
CALCCalcimedica, Inc.Roberts Eric WCHIEF BUSINESS OFFICER, 10%P - Purchase$2.43+6,5001,008,910+1%+$15,810
2025-07-14
CALCCalcimedica, Inc.Leheny A. RachelCEO, 10%P - Purchase$2.47+2,500873,7520%+$6,175
2025-07-11
IONSIonis Pharmaceuticals IncMonia Brett PCEOS - Sale$41.74-1,160179,820-1%-$48,416
D
2025-07-15
INSMInsmed IncLewis WilliamChair, CEOS - Sale+OE$102.38-6,830588,335-1%-$699,220
M
2025-07-11
INSMInsmed IncSmith Michael AlexanderGCS - Sale$99.80-1,68166,394-2%-$167,757
2025-07-14
CYTKCytokinetics IncBlum Robert IPres, CEOS - Sale$38.15-5,000397,274-1%-$190,750
2025-07-14
DYNDyne Therapeutics, Inc.Cox JohnCEO, PresP - Purchase$9.11+100,000274,179+57%+$911,000
2025-07-11
MLYSMineralys Therapeutics, Inc.Congleton JonCEOS - Sale$14.51-15,884846,405-2%-$230,431
2025-07-11
MLYSMineralys Therapeutics, Inc.Levy Adam ScottCFO, SecretaryS - Sale$14.45-10,758206,612-5%-$155,454
D
2025-07-14
MLYSMineralys Therapeutics, Inc.Rodman David MalcomChief Medical OfficerS - Sale+OE$14.59-11,36697,907-10%-$165,879
D
2025-07-14
LQDALiquidia CorpSchundler RussellGCS - Sale+OE$14.28-7,836592,477-1%-$111,898
D
2025-07-14
LQDALiquidia CorpSaggar RajeevChief Medical OfficerS - Sale+OE$14.28-5,327271,413-2%-$76,070
D
2025-07-14
LQDALiquidia CorpMoomaw ScottChief Commercial OfficerS - Sale+OE$14.28-4,797223,231-2%-$68,501
2025-07-14
LQDALiquidia CorpKrepp SarahChief Human Resource OfficerS - Sale$14.28-2,673142,499-2%-$38,170
D
2025-07-14
LQDALiquidia CorpKaseta MichaelCFO, COOS - Sale+OE$14.28-11,580406,412-3%-$165,362
D
2025-07-14
LQDALiquidia CorpJeffs RogerCEOS - Sale+OE$14.28-20,2522,626,822-1%-$289,199
D
2025-07-14
LQDALiquidia CorpJeffs RogerCEOS - Sale+OE$14.28-20,2522,626,822-1%-$289,199
2025-07-14
LQDALiquidia CorpBoyle DanaChief Accounting OfficerS - Sale$14.28-1,193187,168-1%-$17,036
D
2025-07-14
LQDALiquidia CorpAdair JasonChief Business OfficerS - Sale+OE$14.28-2,576193,634-1%-$36,785
D
2025-07-10
AGIOAgios Pharmaceuticals, Inc.Scadden DavidDirS - Sale+OE$40.00-1,40017,603-7%-$56,000
2025-07-11
ANIXAnixa Biosciences IncTitterton Lewis H JrDirP - Purchase$3.14+10,000943,334+1%+$31,400
2025-07-10
IRONDisc Medicine, Inc.Franchi Jean M.CFOS - Sale$57.50-2,00065,530-3%-$115,000
D
2025-07-10
ELVNEnliven Therapeutics, Inc.Hohl BenjaminCFOS - Sale+OE$22.66-1,00023,000-4%-$22,655
D
2025-07-10
CORTCorcept Therapeutics IncSwisher Daniel N JrDirS - Sale+OE$71.08-2,2000-100%-$156,376
D
2025-07-10
UTHRUnited Therapeutics CorpMahon Paul AEVP, GCS - Sale+OE$300.31-11,00036,781-23%-$3,303,394
2025-07-10
COGTCogent Biosciences, Inc.Fairmount Funds Management LLCDirP - Purchase$9.00+2,777,7779,003,418+45%+$24,999,993
2025-07-14
ANIPAni Pharmaceuticals IncCook MeredithSVP, GC, SEC.S - Sale$64.88-40078,945-1%-$25,952
DM
2025-07-10
ARQTArcutis Biotherapeutics, Inc.Burnett PatrickSee RemarksS - Sale+OE$15.05-28,750115,468-20%-$432,700
2025-07-11
ANIXAnixa Biosciences IncKumar AmitCEOP - Purchase$3.15+5,000574,925+1%+$15,750
2025-07-10
AKROAkero Therapeutics, Inc.Cheng AndrewPres, CEOS - Sale$51.16-30,000520,757-5%-$1,534,895
2025-07-10
LGNDLigand Pharmaceuticals IncKozarich John WDirS - Sale$125.00-93446,456-2%-$116,750
M
2025-06-02
CPIXCumberland Pharmaceuticals IncYoung CarolineDirP - Purchase$4.80+8432,6530%+$404
M
2025-06-02
CPIXCumberland Pharmaceuticals IncKazimi A JCOB, CEO, 10%P - Purchase$4.80+1685,699,4280%+$807
M
2025-06-02
CPIXCumberland Pharmaceuticals IncJones JamesDirP - Purchase$4.80+16843,3360%+$807
M
2025-06-02
CPIXCumberland Pharmaceuticals IncKrogulski KennethDirP - Purchase$4.83+935286,6330%+$4,513
2025-07-09
TRDAEntrada Therapeutics, Inc.Parmar KushDir, 10%S - Sale$7.50-27,0004,256,379-1%-$202,554
2025-07-09
TRDAEntrada Therapeutics, Inc.5Am Ventures V, L.P.10%S - Sale$7.50-27,0004,256,379-1%-$202,554
2025-07-09
ONCBeone Medicines Ltd.Oyler JohnCEOS - Sale$253.38-27,80253,867,6490%-$7,044,591
D
2025-07-09
AGIOAgios Pharmaceuticals, Inc.Gheuens SarahChief Medical OfficerS - Sale+OE$37.99-11,91461,271-16%-$452,601
D
2025-07-09
IRONDisc Medicine, Inc.Quisel John DCEOS - Sale+OE$55.33-34,800161,828-18%-$1,925,525
D
2025-07-09
RYTMRhythm Pharmaceuticals, Inc.Smith Hunter CCFOS - Sale+OE$80.48-42,120116,915-26%-$3,389,756
D
2025-07-09
RYTMRhythm Pharmaceuticals, Inc.Shulman JosephChief Technical OfficerS - Sale+OE$77.78-7,9698,509-48%-$619,851
D
2025-07-09
RYTMRhythm Pharmaceuticals, Inc.German Christopher PaulCorporate Controller, CAOS - Sale+OE$80.75-3,817922-81%-$308,217
DM
2025-07-09
NUVLNuvalent, Inc.Pelish Henry E.Chief Scientific OfficerS - Sale+OE$80.31-7,64560,956-11%-$613,986
D
2025-07-09
RYTMRhythm Pharmaceuticals, Inc.Cramer Pamela J.CHROS - Sale+OE$77.13-15,57219,209-45%-$1,201,062
DM
2025-07-09
MRUSMerus N.V.Silverman Peter B.COO, GCS - Sale+OE$55.00-23,5000-100%-$1,292,500
2025-07-09
KALVKalvista Pharmaceuticals, Inc.Palleiko Benjamin LCEOS - Sale$15.69-32,979369,595-8%-$517,523
M
2025-07-08
PBYIPuma Biotechnology, Inc.Nougues Maximo FCFOS - Sale$3.53-9,522204,229-4%-$33,649
M
2025-07-08
PBYIPuma Biotechnology, Inc.Hunt Douglas MSee RemarksS - Sale$3.53-7,817164,894-5%-$27,624
2025-07-09
KALVKalvista Pharmaceuticals, Inc.Yea ChristopherChief Development OfficerS - Sale$15.69-30,250127,939-19%-$474,698
M
2025-07-08
PBYIPuma Biotechnology, Inc.Auerbach Alan HPres, CEO, 10%S - Sale$3.53-47,1727,180,901-1%-$166,702
2025-07-09
CALCCalcimedica, Inc.Roberts Eric WCHIEF BUSINESS OFFICER, 10%P - Purchase$1.60+5,0001,002,410+1%+$8,024
M
2025-07-10
OTLCOncotelic Therapeutics, Inc.Trieu VuongCOB, CEO, 10%P - Purchase$0.01+198,737117,041,2100%+$994
2025-07-09
ABEOAbeona Therapeutics Inc.Silverstein Christine BerniDirS - Sale$5.86-13,093120,479-10%-$76,669
2025-07-09
ABEOAbeona Therapeutics Inc.Seshadri VishwasCEOS - Sale$5.86-69,4201,234,341-5%-$406,503
2025-07-09
ABEOAbeona Therapeutics Inc.Vazzano Joseph WalterCFOS - Sale$5.86-25,411479,168-5%-$148,799
2025-07-08
ABEOAbeona Therapeutics Inc.Wuchterl Donald A.DirS - Sale$5.82-5,176145,436-3%-$30,147
2025-07-09
ABEOAbeona Therapeutics Inc.Charles Faith L.DirS - Sale$5.86-10,738139,094-7%-$62,879
2025-07-09
ABEOAbeona Therapeutics Inc.O'Malley Brendan M.SVP, GCS - Sale$5.86-17,428360,817-5%-$102,053
2025-07-09
ABEOAbeona Therapeutics Inc.Alvino MarkDirS - Sale$5.86-13,09377,252-14%-$76,669
2025-07-08
ELTPElite Pharmaceuticals Inc /Nv/Plassche DouglasEVP OperationsS - Sale$0.58-200,0002,300,000-8%-$115,800
2025-07-07
ELVNEnliven Therapeutics, Inc.Patel AnishCOOS - Sale$19.79-6,667296,642-2%-$131,951
D
2025-07-07
AKROAkero Therapeutics, Inc.Rolph TimothyChief Scientific OfficerS - Sale+OE$51.09-12,500167,124-7%-$638,661
2025-07-07
MURAMural Oncology PlcLoew CarolineCEOS - Sale$2.43-12,531293,059-4%-$30,475
M
2025-07-08
ETSTEarth Science Tech, Inc.Sanchez Yovan ArturoDirP - Purchase$0.18+33,0441,700,000+2%+$5,938

AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top